# The Community Effectiveness of IPTi in Southern Tanzania

> **NCT00152204** · PHASE3 · UNKNOWN · sponsor: **Swiss Tropical & Public Health Institute** · enrollment: 13000 (estimated)

## Conditions studied

- Malaria, Falciparum
- Anemia

## Interventions

- **DRUG:** Sulfadoxine-pyrimethamine used for IPTi
- **DRUG:** IPTi

## Key facts

- **NCT ID:** NCT00152204
- **Lead sponsor:** Swiss Tropical & Public Health Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-03
- **Primary completion:** 2007-12
- **Final completion:** 2008-12
- **Target enrollment:** 13000 (ESTIMATED)
- **Last updated:** 2008-05-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152204, "The Community Effectiveness of IPTi in Southern Tanzania". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00152204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*